Erratum: MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors (International Journal of Cancer (2009) 124:8 (1778-1784) DOI: 10.1002/ijc.24150)

T. Kubo, H. Yamamoto, W. W. Lockwood, I. Valencia, J. Soh, M. Peyton, M. Jida, H. Otani, T. Fujii, M. Ouchida, N. Takigawa, K. Kiura, K. Shimizu, H. Date, J. D. Minna, M. Varella-Garcia, W. L. Lam, A. F. Gazdar, S. Toyooka

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)E1
JournalInternational Journal of Cancer
Volume136
Issue number2
DOIs
StatePublished - Jan 15 2015

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kubo, T., Yamamoto, H., Lockwood, W. W., Valencia, I., Soh, J., Peyton, M., Jida, M., Otani, H., Fujii, T., Ouchida, M., Takigawa, N., Kiura, K., Shimizu, K., Date, H., Minna, J. D., Varella-Garcia, M., Lam, W. L., Gazdar, A. F., & Toyooka, S. (2015). Erratum: MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors (International Journal of Cancer (2009) 124:8 (1778-1784) DOI: 10.1002/ijc.24150). International Journal of Cancer, 136(2), E1. https://doi.org/10.1002/ijc.29178